Connection
Jawahar Mehta to Proteoglycans
This is a "connection" page, showing publications Jawahar Mehta has written about Proteoglycans.
|
|
Connection Strength |
|
 |
|
 |
|
0.311 |
|
|
|
-
Babaahmadi-Rezaei H, Rezaei M, Ghaderi-Zefrehi H, Azizi M, Beheshti-Nasab H, Mehta JL. Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis. Endocr Metab Immune Disord Drug Targets. 2022; 22(12):1191-1200.
Score: 0.194
-
Wang X, Khaidakov M, Guo Z, Ding Z, He Q, Mehta JL. LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II. Cardiovasc Drugs Ther. 2014 Oct; 28(5):441-6.
Score: 0.117